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-(N-Acetylaminomethylene)succinic acid (AAMS) amidohydrolase from
Mesorhizobium loti MAFF303099, which is involved in a degradation pathway
of vitamin B6 and catalyzes the degradation of AAMS to acetic acid, ammonia,
carbon dioxide and succinic semialdehyde, has been overexpressed in
Escherichia coli. To elucidate the reaction mechanism based on the tertiary
structure, the recombinant enzyme was purified and crystallized by the sitting-
drop vapour-diffusion method using PEG 8000 as precipitant. A crystal of the
enzyme belonged to the monoclinic space group C2, with unit-cell parameters
a = 393.2, b = 58.3, c = 98.9 A˚,  = 103.4, and diffraction data were collected to
2.7 A˚ resolution. The VM value and calculation of the self-rotation function
suggested that three dimers with a threefold symmetry were possibly present in
the asymmetric unit.
1. Introduction
-(N-Acetylaminomethylene)succinic acid (AAMS) amidohydrolase
catalyzes the degradation of AAMS to acetic acid, ammonia, carbon
dioxide and succinic semialdehyde as shown in Fig. 1. The enzyme
reaction is the final step in degradation pathway I of vitamin B6
(pyridoxine, pyridoxamine and pyridoxal; Nelson & Snell, 1986). The
enzyme has been found in Pseudomonas MA-1 (Nyns et al., 1969;
Huynh & Snell, 1985) and Mesorhizobium loti (Mukherjee et al.,
2008; Yuan et al., 2008) cells. The enzyme from M. loti, a nitrogen-
fixing symbiotic bacterium, has been cloned, sequenced and char-
acterized. The enzyme is a dimer with a subunit molecular mass of
34 kDa. The amino-acid sequence (AB362478; 278 amino-acid resi-
dues per subunit) has no possible post-translational modifications.
Sequence comparisons suggested thatM. lotiAAMS amidohydrolase
does not contain a signature sequence from any defined protein
family (Yuan et al., 2008), although the enzyme shows a low but
significant (about 27%) identity to fluoroacetate dehalogenase (PDB
code 1y37), haloalkane dehalogenase (PDB code 1k5p) and aryl
esterase (PDB code 1va4).
AAMS amidohydrolase produces four products from the E isomer
of AAMS (Fig. 1). The reaction may involve hydrolytic cleavage of
the amide bond followed by secondary (possibly nonenzymatic)
release of ammonia and decarboxylation (possibly nonenzymatic) of
an intermediate. The enzyme shows no reactivity towards the Z
isomer of AAMS (Mukherjee et al., 2008). Mechanistic analysis of the
enzyme has suggested possible alternate routes for the action of the
enzyme (Nyns et al., 1969; Mukherjee et al., 2008). However, the
catalytic mechanism of the enzyme has not been elucidated because
its tertiary and active-site structure have not been determined. Thus,
no studies have been perfomed on the action of the residues involved
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Figure 1
The enzyme reaction catalyzed by AAMS amidohydrolase.
in the catalytic reaction, although the presence of a catalytic triad in
the active site of the enzyme has been suggested based on the simi-
larity of its amino-acid sequence and predicted secondary structure to
those of aryl esterase (Yuan et al., 2008).
In order to elucidate the catalytic mechanism of AAMS amido-
hydrolase, determination of the three-dimensional structure of this
enzyme is necessary. Here, we describe the crystallization and preli-
minary X-ray diffraction studies of AAMS amidohydrolase from
M. loti.
2. Material and methods
2.1. Overexpression and purification of AAMS amidohydrolase
The cloning of a gene encoding AAMS amidohydrolase and the
overexpression and purification of the enzyme have been reported
previously (Yuan et al., 2008); one additional purification step was
used for crystallization as follows. All purification steps were
performed at 277–283 K. Escherichia coli BL21 (DE3) cells (5.5 g wet
weight) harbouring plasmid pET6787 and overexpressing AAMS
amidohydrolase were suspended in 25 ml 50 mM potassium phos-
phate buffer pH 7.0 containing 0.1%(v/v) 2-mercaptoethanol (buffer
A) and 0.1 mM phenylmethylsulfonyl fluoride. The cell suspension
was sonicated on ice for 6 min with a Heatsystems-Ultrasonics soni-
cator W-220. After centrifugation at 10 000g for 20 min at 277 K,
the supernatant was stored. The precipitated cells and debris were
resuspended in 20 ml buffer A containing phenylmethylsulfonyl
fluoride, sonicated and centrifuged. The second supernatant was
mixed with the first supernatant to make the crude extract. The crude
extract (44 ml) was fractionated with ammonium sulfate. The preci-
pitate obtained after centrifugation of a 40–55% saturated solution
was dissolved in 15 ml buffer A and then dialyzed thoroughly against
buffer A. 1M (final concentration) ammonium sulfate solution was
added to the dialyzed solution and the enzyme solution was then
applied onto a Butyl-Toyopearl 650 M column (3.0  17.0 cm; Tosoh
Corporation, Tokyo, Japan) equilibrated with buffer A containing
1M ammonium sulfate. The enzyme was eluted at around 0.4M
ammonium sulfate with a linear gradient (1.0–0M ammonium
sulfate). The active fractions were pooled and dialyzed thoroughly
against buffer B (50 mM Tris–HCl pH 7.0 containing 0.1% 2-mer-
captoethanol). The dialyzed solution was applied onto a hydroxyl-
apatite (Nacalai Tesque, Kyoto, Japan, 100–200 mesh) column (1.5 
16.0 cm) equilibrated with buffer B. The enzyme was eluted at around
10 mM potassium phosphate pH 7.0 with a linear gradient of 0–
50 mM potassium phosphate. Ammonium sulfate (55% saturation)
was added to the active fraction and the precipitate was collected by
centrifugation (10 000g for 20 min at 277 K). The precipitate was
dissolved in 1.0 ml 50 mM Tris–HCl pH 7.0 containing 0.1%(v/v)
2-mercaptoethanol and the enzyme solution was applied onto a
HPLC gel-filtration column (5-diol-300II; Nacalai Tesque, Kyoto,
Japan) equilibrated with buffer B as an additional purification step.
The enzyme was eluted from the column as a single peak, the elution
volume of which corresponded to a dimer. The purified enzyme was
dialyzed against 10 mM HEPES pH 7.0 containing 0.1%(v/v)
2-mercaptoethanol and concentrated to 14 mg ml1 with an Amicon
Ultra-4 30 kDa Ultracel (Millipore, Billerica, Massachusetts, USA)
for crystallization.
2.2. Enzyme assay
AAMS amidohydrolase activity was measured to identify the
fractions to be collected during the purification steps. AAMS
amidohydrolase activity was determined by measuring the initial
decrease in A261 of AAMS at 298 K in a reaction mixture consisting
of 50 mM potassium phosphate buffer pH 7.0, 0.025 mM AAMS and
the enzyme. One unit of enzyme was defined as the amount of
enzyme that catalyzed the hydrolysis of 1 mmol of the substrate per
minute. The substrate concentration was near the Km value to make
the original absorbance at 261 nm precisely measurable.
2.3. Crystallization and X-ray analysis
The initial crystallization conditions were screened using Crystal
Screen I, PEG/Ion Screen (Hampton Research, California, USA) and
Wizard Screens I and II (Emerald BioSystems, Washington, USA).
The enzyme was crystallized at 293 K by the sitting-drop vapour-
diffusion method using CrystalClear Strips from Hampton Research
(Laguna Niguel, California, USA). Crystals appeared within three
weeks during equilibration of a droplet consisting of a mixture of the
same volumes (2 ml) of protein and reservoir solution [Wizard Screen
II condition No. 3; 100 mM Tris–HCl buffer final pH 8.5, 20%(w/v)
PEG 3000, 200 mM MgCl2] against a reservoir containing 100 ml of
the latter solution. The drops were set up manually. To optimize the
crystallization condition, 40%(v/v) 2,2,2-trifluoroethanol (solution
No. 95 from Additive Screen, Hampton Research, California, USA)
was applied. After improvement of the conditions, the reservoir
solution was changed to 100 mM Tris–HCl buffer (final pH 8.5),
20%(w/v) PEG 8000, 275 mM MgCl2. Thus, a droplet of the enzyme
mixture was prepared by mixing 2 ml enzyme solution (14 mg ml1)
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Figure 2
SDS–PAGE analysis of purified AAMS amidohydrolase. Lane 1, molecular-weight
markers. Lane 2, purified AAMS amidohydrolase for crystallization.
Table 1
Data-collection statistics of AAMS amidohydrolase.
Values in parentheses are for the highest resolution bin (2.80–2.70 A˚).
Temperature (K) 100
Wavelength (A˚) 1.0
Resolution range (A˚) 50–2.7
No. of measured reflections 162075
No. of unique reflections 61051
Completeness (%) 95.9 (97.5)
Mean I/(I) 9.2 (2.63)
Rmerge† (%) 13 (31.3)
Space group C2
Unit-cell parameters
a (A˚) 393.2
b (A˚) 58.3
c (A˚) 98.9
 () 103.4
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith measure-
ment and hI(hkl)i is the weighted mean of all measurements of I(hkl).
with 2 ml 80 mM Tris–HCl buffer pH 8.5, 16%(w/v) PEG 8000,
220 mMMgCl2, 8%(v/v) 2,2,2-trifluoroethanol. The optimized crystals
grew from the droplet in three weeks at 293 K (Fig. 2).
Data collection was carried out using synchrotron radiation on
beamline KEK AR-NW12A at Photon Factory (Tsukuba, Japan).
The crystal was soaked for a few seconds in reservoir solution con-
taining 30%(v/v) glycerol and flash-cooled in a liquid-nitrogen gas
stream. Diffraction data were collected at 100 K using an ADSC/
CCD detector system. Data processing was carried out using the
program HKL-2000 (Otwinowski & Minor, 1997) at the beamline
station. The data-collection statistics are listed in Table 1.
3. Results and discussion
AAMS amidohydrolase was successfully overexpressed in E. coli and
purified, maintaining significant enzyme activity. The results of SDS–
PAGE analysis of the purified enzyme are shown in Fig. 2.
A crystal suitable for X-ray data collection, which grew to
dimensions of 0.14  0.06  0.01 mm in three weeks after setup, is
shown in Fig. 3. The crystal of AAMS amidohydrolase diffracted to a
resolution of 2.7 A˚, as shown in Fig. 4, and a complete data set was
successfully collected to 2.7 A˚ resolution, as summarized in Table 1.
The crystal belonged to the monoclinic space group C2, with unit-cell
parameters a = 393.2, b = 58.3, c = 98.9 A˚,  = 103.4.
The asymmetric unit is expected to contain 6–8 molecules, with a
crystal volume per unit molecular weight VM of 3.07–2.31 A˚
3 Da1,
corresponding to a solvent content of 60–47% (Matthews, 1968).
Calculation of the self-rotation function using the program
POLARRFN from the CCP4 program suite (Collaborative Compu-
tational Project 4, Number 4, 1994) revealed a clear local threefold
axis, ! = 75.2 (the inclination to the z axis within the yz plane),
’ = 0.0 (within the xy plane),  = 120.2, peak height = 67.3, and no
other local symmetry could be found. Since AAMS amidohydrolase
has been reported to form a dimer (Yuan et al., 2008), three dimers
are possibly arranged with threefold symmetry in the asymmetric
unit. The molecular-replacement method was attempted using the
MOLREP program from the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994) with the structures of
fluoroacetate dehalogenase (PDB code 1y37), haloalkane dehalo-
genase (1k5p) and aryl esterase (1va4) as models, but a plausible
solution could not be obtained.
We are currently refining the crystallization conditions to obtain
better diffracting crystals and preparing a selenomethionine deriva-
tive of the enzyme for further analysis.
This research was performed with the approval of the Photon
Factory Advisory Committee and the National Laboratory for High
Energy Physics, Japan.
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Figure 3
Crystal of M. loti AAMS amidohydrolase with dimensions of 0.14  0.06 
0.01 mm.
Figure 4
Diffraction image of M. loti AAMS amidohydrolase; the ring indicates 2.7 A˚
resolution.
